
TY  - JOUR
TI  - The International Liver Transplantation Society: 15th Annual International Congress
JO  - Liver Transplantation
JA  - Liver Transpl
VL  - 15
IS  - S7
SN  - 1527-6465
UR  - https://doi.org/10.1002/lt.21830
DO  - doi:10.1002/lt.21830
SP  - S1
EP  - S299
PY  - 2009
ER  - 

TY  - JOUR
TI  - The ILTS 18th Annual International Congress
JO  - Liver Transplantation
JA  - Liver Transpl
VL  - 18
IS  - S1
SN  - 1527-6465
UR  - https://doi.org/10.1002/lt.23435
DO  - doi:10.1002/lt.23435
SP  - S1
EP  - S306
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Thrombosis and Haemostasis
JA  - Journal of Thrombosis and Haemostasis
VL  - 5
IS  - S2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2007.tb00011.x
DO  - doi:10.1111/j.1538-7836.2007.tb00011.x
SP  - P-S-407
EP  - P-S-599
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - American Journal of Transplantation
VL  - 18
IS  - S4
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.14918
DO  - doi:10.1111/ajt.14918
SP  - 479
EP  - 991
PY  - 2018
ER  - 

TY  - JOUR
TI  - 2014 ACVIM Forum Research Abstracts Program
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 28
IS  - 3
SN  - 0891-6640
UR  - https://doi.org/10.1111/jvim.12361
DO  - doi:10.1111/jvim.12361
SP  - 976
EP  - 1134
PY  - 2014
ER  - 

TY  - JOUR
TI  - Keyword index
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - 12
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.01582.x
DO  - doi:10.1111/j.1365-2362.2005.01582.x
SP  - 791
EP  - 793
PY  - 2005
ER  - 

TY  - JOUR
TI  - 6th Congress of the European College of Equine Internal Medicine
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 28
IS  - 2
SN  - 0891-6640
UR  - https://doi.org/10.1111/jvim.12326
DO  - doi:10.1111/jvim.12326
SP  - 696
EP  - 710
PY  - 2014
ER  - 

AU  - Pitcher, Harrison T.
AU  - Harrison, Timothy J.
C7  - pp. 22-40
TI  - Arrhythmias, Acute Coronary Syndromes, and Hypertensive Emergencies
SN  - 9780470654613
UR  - https://doi.org/10.1002/9781118274231.ch3
DO  - doi:10.1002/9781118274231.ch3
SP  - 22-40
KW  - arrhythmias, acute coronary syndromes, hypertensive emergencies
KW  - cardiac action, except in phase 3, conductance, low
KW  - vascular supply to cardiac conduction, except in blood to anterior fascicle
KW  - Wolff–Parkinson–White syndrome, atrioventricular reentrant tachycardia
KW  - Takotsubo's syndrome, or broken heart syndrome, transient cardiomyopathy
KW  - “falling a lot lately,” Mobitz type I (Wenckebach)
KW  - left anterior fascicular block, except in right axis deviation
KW  - hypertensive emergency, urgency, end organ damage, in elderly, African Americans
KW  - acute pericarditis, myocardial, thrombolytics, least indicated
KW  - myocardial complication and mitral regurgitation severity
PY  - 2014
ER  - 

TY  - JOUR
TI  - Scientific Program
JO  - Internal Medicine Journal
VL  - 38
IS  - s5
SN  - 9780470654613
UR  - https://doi.org/10.1111/j.1445-5994.2008.01803.x
DO  - doi:10.1111/j.1445-5994.2008.01803.x
SP  - x
EP  - xiii
PY  - 2008
ER  - 

TY  - JOUR
TI  - Molecular biology of muscle development
JO  - Journal of Cellular Biochemistry
JA  - J. Cell. Biochem.
VL  - 56
IS  - S18D
SN  - 9780470654613
UR  - https://doi.org/10.1002/jcb.240560810
DO  - doi:10.1002/jcb.240560810
SP  - 461
EP  - 541
PY  - 1994
ER  - 

AU  - Nguyen, Thach
AU  - Bo, Xu
AU  - Latif, Faisal
AU  - Dung, Ho Thuong
AU  - Pinto, Duane
AU  - Hung, Pham Manh
AU  - Gibson, Michael
AU  - Gao, Runlin
C7  - pp. 113-140
TI  - ST Segment Elevation Myocardial Infarction
SN  - 9781118965030
UR  - https://doi.org/10.1002/9781118965061.ch5
DO  - doi:10.1002/9781118965061.ch5
SP  - 113-140
KW  - angioplasty
KW  - brain natriuretic peptide
KW  - coronary angiogram
KW  - electrocardiogram
KW  - myocardial injuries
KW  - ST segment elevation myocardial infarction
KW  - thrombolytic therapy
PY  - 1994
AB  - Summary This chapter presents the background, challenges, strategic mapping, high-risk markers, high-risk predictors, investigations, smart testing, management, comprehensive management and preferential management for ST segment elevation myocardial infarction (STEMI). The signs suggesting extensive myocardial injuries include high white blood cell count and elevated brain natriuretic peptide level (BNP). Chest pain may radiate to the left arm, neck, jaw, back or to the epigastric area. Many patients complain of chest tightness rather than chest pain. Some patients, especially the elderly, and women may present with acute shortness of breath, dizziness, pre-syncope, or syncope, nausea and vomiting, rather than classical angina. In the acute setting of STEMI, only the electrocardiogram (ECG), and basic blood tests of complete blood count and electrolytes (sodium, potassium), blood urea nitrogen, creatinine level, protime and prothrombin time are needed before the patient receives thrombolytic therapy or undergoes urgent coronary angiogram for possible angioplasty.
ER  - 

TY  - JOUR
TI  - Index
JO  - Journal of Cardiovascular Electrophysiology
VL  - 18
IS  - s2
SN  - 9781118965030
UR  - https://doi.org/10.1111/j.1540-8167.2007.00933_1.x
DO  - doi:10.1111/j.1540-8167.2007.00933_1.x
SP  - S1
EP  - S68
PY  - 2007
ER  - 

AU  - Hohnloser, Stefan H.
AU  - Camm, John
AU  - Cappato, Riccardo
AU  - Diener, Hans-Christoph
AU  - Heidbuchel, Hein
AU  - Lanz, Hans-Joachim
AU  - Mont, Lluís
AU  - Morillo, Carlos A.
AU  - Smolnik, Rüdiger
AU  - Yin, Ophelia Q.P.
AU  - Kautzner, Josef
C7  - pp. 241-245
C8  - CLC-17-0880.R1
TI  - Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study.
SN  - 9781119044161
UR  - https://doi.org/10.1002/9781119044246.index
DO  - doi:10.1002/9781119044246.index
SP  - 241-245
KW  - Atrial Fibrillation
KW  - Catheter Ablation
KW  - Direct Oral Anticoagulant
KW  - Direct Oral Anticoagulant Edoxaban
KW  - Non–Vitamin K Oral Anticoagulants
KW  - Periprocedural
PY  - 2007
AB  - Patients with atrial fibrillation (AF) are at an approximately 0.5% to 3% increased risk of thromboembolism during and immediately after catheter ablation. Treatment guidelines recommend periprocedural oral anticoagulation plus unfractionated heparin during ablation. Rivaroxaban and dabigatran are the only non?vitamin K oral anticoagulants for which there are randomized controlled trials assessing uninterrupted anticoagulation in patients undergoing catheter ablation of AF. Edoxaban, a direct factor Xa inhibitor, is noninferior vs warfarin for the prevention of stroke or systemic embolism with less major bleeding in patients with nonvalvular AF. The ELIMINATE-AF (Evaluation of Edoxaban Compared With VKA in Subjects Undergoing Catheter Ablation of Nonvalvular Atrial Fibrillation) trial is a multinational, multicenter, prospective, randomized, open-label, parallel-group, blinded-endpoint evaluation (PROBE) study to assess the safety and efficacy of once-daily edoxaban 60?mg (30?mg in patients indicated for a dose reduction) vs vitamin K antagonists (VKA) in patients with nonvalvular AF undergoing catheter ablation (http://www.ClinicalTrials.gov: NCT02942576). A total of 560 patients are planned for randomization to edoxaban or VKA (2:1 ratio) to obtain 450 patients fully compliant with the protocol. Patients will complete 21 to 28?days of anticoagulation prior to the ablation and a 90-day post-ablation period. The primary efficacy endpoint is the composite of all-cause death, stroke, and major bleeding. The primary safety endpoint is major bleeding. A magnetic resonance imaging substudy will assess the incidence of silent cerebral lesions post-ablation. ELIMINATE-AF will define the efficacy and safety of edoxaban for uninterrupted oral anticoagulation during catheter ablation of AF.
ER  - 

TY  - JOUR
TI  - The following abstracts were presented at the Annual Meeting of the Group of Anaesthetists in Training (GAT) in Oxford, April 2013
JO  - Clinical Cardiology
JA  - Anaesthesia
VL  - 41
IS  - 4
SN  - 9781119044161
UR  - https://doi.org/10.1002/clc.22918
DO  - doi:10.1002/clc.22918
SP  - 440
EP  - 449
PY  - 2018
ER  - 

TY  - JOUR
TI  - ESSR ABSTRACTS 2010
JO  - Anaesthesia
JA  - Br J Surg
VL  - 68
IS  - 9
SN  - 9781119044161
UR  - https://doi.org/10.1111/anae.12345
DO  - doi:10.1111/anae.12345
SP  - 987
EP  - 993
PY  - 2013
AB  - Abstract The 45th Congress of the European Society for Surgical Research takes place this year in Geneva, Switzerland, 9?12 June 2010, under the presidency of Mustafa Cikirikcioglu, MD, PhD. Copyright ? 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
AU  - Wu, Ying
AU  - Xiao, Ying-Xiu
AU  - Huang, Teng-Yi
AU  - Zhang, Xian-Yan
AU  - Zhou, Huan-Bing
AU  - Zhang, Xue-Xuan
AU  - Wu, Ying-E
TI  - What makes D-dimer assays suspicious–heterophilic antibodies?
JO  - BJS (British Journal of Surgery)
JA  - J Clin Lab Anal
VL  - 97
IS  - S4
SN  - 9781119044161
UR  - https://doi.org/10.1002/bjs.7159
DO  - doi:10.1002/bjs.7159
SP  - S59
EP  - S121
KW  - D-dimer
KW  - D-dimer assays
KW  - Heterophilic antibody
KW  - Immunoassay
KW  - Interference
PY  - 2010
AB  - Background Heterophilic antibodies are still an important source of interference in immunoassays, but reports of interference with D-dimers are rare. Are D-dimer level abnormalities, found in the clinic, caused by heterophilic antibodies as well, or are other mechanisms involved? We will elaborate on this issue through two different examples in this article. Methods Serum from two patients with significantly elevated levels of D-dimers were measured and compared by different methods, diluted, and dealt with heterophilic antibody blockers. At the same time, to retrieve the interference, we focused on the cause of D-dimer false positives and made a systematic review of the literature. Results The D-dimer values were normal (0.49 and 0.15 ?g/mL) detected with different testing method and decreased after addition of heterophilic antibody blocking reagent. According to literature data, there were 66.7% (4/6) references showed the interference were heterophilic antibody. Conclusions The influence of heterophilic antibodies on the measurement of D-dimers remains a big challenge. Different measuring instruments and methods may have significant differences in the measurement of D-dimers. By using a combination of instrumental methods for measuring, incorporating heterophilic antibody blockers, and combining with clinical performance and imaging data, most of the interference can be eliminated.
ER  - 

TY  - JOUR
C7  - e22687
TI  - Clinical Nutrition Week 2010 Scientific Abstracts
JO  - Journal of Clinical Laboratory Analysis
JA  - Journal of Parenteral and Enteral Nutrition
VL  - 33
IS  - 2
SN  - 9781119044161
UR  - https://doi.org/10.1002/jcla.22687
DO  - doi:10.1002/jcla.22687
SP  - e22687
PY  - 2019
ER  - 

TY  - JOUR
TI  - Paper Abstract
JO  - Journal of Parenteral and Enteral Nutrition
JA  - J Am Geriatr Soc
VL  - 34
IS  - 2
SN  - 9781119044161
UR  - https://doi.org/10.1177/0148607110362660
DO  - doi:10.1177/0148607110362660
SP  - 171
EP  - 235
PY  - 2010
ER  - 

TY  - JOUR
TI  - Oral presentations
JO  - Journal of the American Geriatrics Society
VL  - 62
IS  - s1
SN  - 9781119044161
UR  - https://doi.org/10.1111/jgs.12870
DO  - doi:10.1111/jgs.12870
SP  - S1
EP  - S331
PY  - 2014
ER  - 

TY  - JOUR
TI  - Oral presentations
JO  - Journal of Thrombosis and Haemostasis
VL  - 7
IS  - s2
SN  - 9781119044161
UR  - https://doi.org/10.1111/j.1538-7836.2009.03473_1.x
DO  - doi:10.1111/j.1538-7836.2009.03473_1.x
SP  - 1
EP  - 316
PY  - 2009
ER  - 
